Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2026
Zerodha launches US stock investing in beta on Kite
Zerodha launched its US stock investing facility in beta on Kite, allowing eligible Indian residents to invest in US-listed stocks and ETFs through their existing Zerodha accounts.
2021
Zerodha adds Sticky Order Window and Leverage Indicator to Kite
Zerodha introduced the Sticky Order Window and Leverage Indicator features on its Kite stock-trading app. The features keep the order window open for repeated orders and show the leverage available for an equity trade.
2021
Kite and Shoreline Biosciences enter cell-therapy partnership
Kite and Shoreline Biosciences entered into a strategic partnership to develop novel allogeneic cell therapies across a range of cancer targets. Shoreline will contribute expertise in induced pluripotent stem cells and genetic reprogramming, while Kite will contribute cell-therapy development, commercialisation and manufacturing expertise.
2021
Zerodha launches equity and ETF SIP feature
Zerodha launched a feature allowing investors to set up systematic investment plans for stocks and ETFs; it was in beta and available on Kite web.
2020
FDA grants accelerated approval to Tecartus
The U.S. Food and Drug Administration granted accelerated approval to Tecartus for treating adults with relapsed or refractory mantle cell lymphoma.